Company LungLife AI, Inc. Deutsche Boerse AG
Equities
9H4
USU5500L1045
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.172 EUR | 0.00% |
|
-6.52% | -76.44% |
04-05 | Transcript : LungLife AI, Inc., 2023 Earnings Call, Apr 05, 2024 | |
04-04 | LungLife reports narrowed losses in year of "considerable achievement" | AN |
Business Summary
Number of employees: 15
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Royalty
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +89.93% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +89.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 40 | - |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
Chief Tech/Sci/R&D Officer | - | - | |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Rebecca Reed
LAW | General Counsel | - | - |
Lara Baden
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gordon Davis
CHM | Chairman | 67 | 21-07-07 |
Andrew Boteler
BRD | Director/Board Member | 58 | 21-07-07 |
David Anderson
DFI | Director of Finance/CFO | 61 | - |
James McCullough
BRD | Director/Board Member | 56 | 18-12-31 |
Sara Barrington
BRD | Director/Board Member | 57 | 21-07-07 |
Paul Pagano
CEO | Chief Executive Officer | 40 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,658,603 | 15,817,963 ( 51.59 %) | 0 | 51.59 % |
Company contact information
LungLife AI, Inc.
2545 West Hillcrest Drive Suite 140
91320, Thousand Oaks
+805 409 9868
http://www.lunglifeai.com![address LungLife AI, Inc.(9H4)](https://cdn.zonebourse.com/static/address/131301227.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.89% | 7.8B | |
+6.77% | 3.53B | |
-1.35% | 2.24B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
+29.42% | 811M | |
-12.66% | 670M | |
-26.12% | 533M |
- Stock Market
- Equities
- LLAI Stock
- 9H4 Stock
- Company LungLife AI, Inc.